Literature DB >> 9746125

Trends in blood pressure levels and control of hypertension in Finland from 1982 to 1997.

M J Kastarinen1, V V Salomaa, E A Vartiainen, P J Jousilahti, J O Tuomilehto, P M Puska, A M Nissinen.   

Abstract

OBJECTIVE: To assess the trends in blood pressure levels and hypertension control in Finland from 1982 to 1997.
DESIGN: Four independent cross-sectional population surveys conducted in 1982, 1987, 1992 and 1997.
SETTING: From 1982 to 1997, the provinces of North Karelia and Kuopio in eastern Finland and the region of Turku-Loimaa in southwestern Finland were surveyed. From 1992 to 1997, the Helsinki-Vantaa region in southern Finland was surveyed. PARTICIPANTS: Men and women aged 25-64 years were selected randomly from the national population register. The total number of participants was 27 623. MAIN OUTCOME MEASURES: We assessed mean systolic and diastolic blood pressure, prevalence of hypertension (subjects with systolic blood pressure > or = 160 mmHg or diastolic blood pressure > or = 95 mmHg or current use of antihypertensive drug treatment) and antihypertensive drug treatment and quality of hypertension care among hypertensive persons.
RESULTS: Mean systolic blood pressure and the prevalence of hypertension decreased significantly in all areas except among men in the Helsinki-Vantaa region. The fall in mean diastolic pressure was significant only in eastern Finland. The proportion of hypertensives who were unaware of their condition fell from 45.5 to 24.1% in men and from 27.2 to 15.7% in women. At the same time, the proportion of hypertensives with adequately controlled blood pressure (systolic pressure < 160 mmHg and diastolic pressure < 95 mmHg) increased from 9.4 to 23.5% in men and from 16.0 to 36.7% in women.
CONCLUSION: Hypertension care in Finland has improved significantly during the last 15 years. However, the situation is still far from optimal. It is obvious that the biggest problem in hypertension care has shifted from detection to adequate treatment of high blood pressure.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9746125     DOI: 10.1097/00004872-199816090-00019

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  10 in total

Review 1.  Salt restriction for the prevention of cardiovascular disease.

Authors:  Dieter Klaus; Joachim Hoyer; Martin Middeke
Journal:  Dtsch Arztebl Int       Date:  2010-07-02       Impact factor: 5.594

2.  Evolution of cardiovascular risk factors among 18-year-old males in Austria between 1986 and 2005.

Authors:  Astrid Wallner; Alexandra Hirz; Edith Schober; Harald Harbich; Thomas Waldhoer
Journal:  Wien Klin Wochenschr       Date:  2010-03       Impact factor: 1.704

3.  Trends in hypertension management in Type I diabetes across Europe, 1989/1990 - 1997/1999.

Authors:  S S Soedamah-Muthu; H M Colhoun; H Abrahamian; N N Chan; R Mangili; G P Reboldi; J H Fuller
Journal:  Diabetologia       Date:  2002-09-07       Impact factor: 10.122

4.  Trends in the prevalence and treatment of hypertension in Halifax County from 1985 to 1995.

Authors:  H K Wolf; P Andreou; I R Bata; D G Comeau; R D Gregor; G Kephart; D R MacLean; I Sketris
Journal:  CMAJ       Date:  1999-09-21       Impact factor: 8.262

5.  Long-term metabolic fate and mortality in obesity without metabolic syndrome.

Authors:  Aki Juhani Käräjämäki; Arto Korkiakoski; Janne Hukkanen; Y Antero Kesäniemi; Olavi Ukkola
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

6.  Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure.

Authors:  Christopher Newton-Cheh; Martin G Larson; Ramachandran S Vasan; Daniel Levy; Kenneth D Bloch; Aarti Surti; Candace Guiducci; Sekar Kathiresan; Emelia J Benjamin; Joachim Struck; Nils G Morgenthaler; Andreas Bergmann; Stefan Blankenberg; Frank Kee; Peter Nilsson; Xiaoyan Yin; Leena Peltonen; Erkki Vartiainen; Veikko Salomaa; Joel N Hirschhorn; Olle Melander; Thomas J Wang
Journal:  Nat Genet       Date:  2009-02-15       Impact factor: 38.330

Review 7.  Hypertension and hypercholesterolaemia as risk factors for Alzheimer's disease: potential for pharmacological intervention.

Authors:  Miia Kivipelto; Mikko P Laakso; Jaakko Tuomilehto; Aulikki Nissinen; Hilkka Soininen
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

8.  Incidence of hypertension in Korea: 5-year follow-up study.

Authors:  Jang Hoon Lee; Dong Heon Yang; Hun Sik Park; Yongkeun Cho; Jae Eun Jun; Wee Hyun Park; Byung Yeol Chun; Ji-Yeon Shin; Dong Hoon Shin; Kyeong Soo Lee; Kee-Sik Kim; Kwon-Bae Kim; Young Jo Kim; Shung Chull Chae
Journal:  J Korean Med Sci       Date:  2011-10-01       Impact factor: 2.153

9.  Change in antihypertensive drug prescribing after guideline implementation: a controlled before and after study.

Authors:  Raija Sipilä; Arja Helin-Salmivaara; Maarit Jaana Korhonen; Eeva Ketola
Journal:  BMC Fam Pract       Date:  2011-08-17       Impact factor: 2.497

10.  An international comparative study of blood pressure in populations of European vs. African descent.

Authors:  Richard S Cooper; Katharina Wolf-Maier; Amy Luke; Adebowale Adeyemo; José R Banegas; Terrence Forrester; Simona Giampaoli; Michel Joffres; Mika Kastarinen; Paola Primatesta; Birgitta Stegmayr; Michael Thamm
Journal:  BMC Med       Date:  2005-01-05       Impact factor: 8.775

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.